Home    

Sea cucumber

The sea cucumber, the proteins it produces are the subject of ongoing research funded by Reef Health.

 

If you are looking for the
Reef Health Online Store, it can be found here

Reef Health Store



Working together for a healthier life

 

We are pleased to introduce you to Reef Health, a natural health company focused on today's needs.

Headquartered in Sydney, Reef Health researches, develops, manufactures and markets innovative products for longer, healthier lives.

Reef Health has strengths in health care, Traditional Chinese Medicine and complimentary medicines, mobility devices, after surgical care requisites, research and patented medicines.

  • Increasing innovation in our R&D
    By focusing on patients’ needs, we intend to become the most productive R&D organisation in the healthcare sector. To do this, we are carrying out a complete review of our portfolio. Moving forward, we will evolve our decision-making process, creating an innovative and dynamic organisation, developing a clear strategy to tap into the best science around the world.

  • Adapting our company to future challenges
    The crucial questions facing our industry are clear: “How can we broaden the view to treating the whole patient and realising just how complex the human body is and that one size cannot fit all? How can we create more sustainable growth?” To answer these questions, we have to identify the resources and the competencies we need to grow.We are growing in markets as diverse as the patients themselves. New technologies open new avenues of research, biologicals, branded generics and consumer healthcare (OTC) require our teams to move out of the classical pharmaceutical mindset. Our company has a history of adapting to opportunity and we will build upon this strength.

  • Pursuing external growth opportunities
    Why must we diversify? Classical small molecules pharmaceuticals, are vulnerable.So we want to build businesses like Traditional Chinese Medicine, like consumer health care, like branded generics, to create a basis for more sustainable growth. We will of course maintain our pharmaceutical business, but we will also reply to future healthcare challenges with a broader platform of offerings, which are more affordable and accessible to patients with fewer economic resources. We are striving do develop new export markets to increase our exposure and opportunities, particularly in China and South America.